Skip to main content
Amanda Gillispie, PharmD, BCPPS

Amanda Gillispie, PharmD, BCPPS

  • Clinical Pharmacy Specialist

Departments

Board Certification

  • BCPPS

Education

  • PharmD – University of Iowa College of Pharmacy, Iowa City, Iowa

Post-Graduate Training

  • PGY1 Pharmacy Practice Residency – Primary Children’s Hospital, Salt Lake City, Utah
  • PGY2 Oncology Practice Residency – St. Jude Children’s Research Hospital, Memphis, Tennessee

Honors/Awards

  • 2023 – Texas Children’s PGY-2 Pharmacy Residency Preceptor of the Year
  • 2022 – Texas Children’s Cancer and Hematology Center Quarterly Employee Recognition (Bravo Award) Recipient

Pharmacy Organizations/Committee Service

  • American Society for Transplant and Cellular Therapy 
  • Children’s Oncology Group

Selected Publications

Llaurador G, Shaver K, Wu M, Wang T, Gillispie A, Doherty E, Craddock J, Read J, Yassine K, Morales E, George A, Steffin D, Krance R, Martinez C, Heslop H, Salem B. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Feb;30(2):217-227. doi: 10.1016/j.jtct.2023.10.024.

Díaz Vidal VC, Gillispie A, Aranda C, Anvari S. Successful Elosulfase Alfa Desensitization Protocol in a Patient With Morquio A Syndrome. Pediatrics. 2022;149(2):e2021052648. doi:10.1542/peds.2021-052648. 

Stubbs LA, Szafron V, Forbes LR, Musick MA, Gillispie AE, et al. Severe Pediatric COVID-19 Pneumonia Treated with Adjuvant Anakinra. Hosp Pediatr. 2022;12(5):e162-e170. Doi:10.1542/hpeds.2021-006376.

Last update: October 2024

Close